PortfoliosLab logoPortfoliosLab logo
RMD vs. JPM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RMD vs. JPM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ResMed Inc. (RMD) and JPMorgan Chase & Co. (JPM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RMD achieves a -18.50% return, which is significantly lower than JPM's 11.17% return. Over the past 10 years, RMD has underperformed JPM with an annualized return of 12.73%, while JPM has yielded a comparatively higher 21.76% annualized return.


RMD

1D
1.76%
1M
-0.63%
6M
-22.22%
YTD
-18.50%
1Y
-27.90%
3Y*
-2.95%
5Y*
-4.72%
10Y*
12.73%
ALL TIME*
20.29%

JPM

1D
0.95%
1M
6.40%
6M
19.78%
YTD
11.17%
1Y
21.38%
3Y*
34.00%
5Y*
21.59%
10Y*
21.76%
ALL TIME*
12.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$3.24B$3.50B$3.02B
$244.63M$304.67M$312.92M

RMD vs. JPM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
RMD
ResMed Inc.
-18.50%6.26%34.18%-16.55%-19.47%23.41%38.33%37.85%36.38%39.06%
JPM
JPMorgan Chase & Co.
11.17%37.27%44.29%30.63%-12.64%27.75%-5.53%47.26%-6.62%26.76%

Correlation

The correlation between RMD and JPM is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Jun 2, 1995

0.26

Fundamentals

Market Cap

RMD:

$28.33B

JPM:

$946.43B

EPS

RMD:

$15.50

JPM:

$23.29

PE Ratio

RMD:

12.60

JPM:

15.17

PEG Ratio

RMD:

0.39

JPM:

1.67

PS Ratio

RMD:

3.46

JPM:

3.32

Total Revenue (TTM)

RMD:

$5.54B

JPM:

$297.63B

Gross Profit (TTM)

RMD:

$3.42B

JPM:

$186.33B

EBITDA (TTM)

RMD:

$2.10B

JPM:

$90.84B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RMD vs. JPM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RMD
RMD Risk / Return Rank: 1010
Overall Rank
RMD Sharpe Ratio Rank: 55
Sharpe Ratio Rank
RMD Sortino Ratio Rank: 99
Sortino Ratio Rank
RMD Omega Ratio Rank: 1010
Omega Ratio Rank
RMD Calmar Ratio Rank: 1717
Calmar Ratio Rank
RMD Martin Ratio Rank: 99
Martin Ratio Rank

JPM
JPM Risk / Return Rank: 7373
Overall Rank
JPM Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
JPM Sortino Ratio Rank: 7070
Sortino Ratio Rank
JPM Omega Ratio Rank: 6969
Omega Ratio Rank
JPM Calmar Ratio Rank: 7474
Calmar Ratio Rank
JPM Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RMD vs. JPM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RMDJPMDifference
Sharpe ratioReturn per unit of total volatility

-2.01

Sortino ratioReturn per unit of downside risk

-2.81

Omega ratioGain probability vs. loss probability

0.83

1.18

-0.34

Calmar ratioReturn relative to maximum drawdown

-0.75

1.39

-2.14

Martin ratioReturn relative to average drawdown

-1.42

3.28

-4.71

RMD vs. JPM - Sharpe Ratio Comparison

The current RMD Sharpe Ratio is -1.04, which is lower than the JPM Sharpe Ratio of 0.97. The chart below compares the historical Sharpe Ratios of RMD and JPM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RMD vs. JPM - Drawdown Comparison

The maximum RMD drawdown since its inception was -61.61%, smaller than the maximum JPM drawdown of -76.16%. Use the drawdown chart below to compare losses from any high point for RMD and JPM.


Loading charts...

Drawdown Indicators


RMDJPMDifference

Max Drawdown

Largest peak-to-trough decline

-61.61%

-76.16%

+14.55%

Max Drawdown (1Y)

Largest decline over 1 year

-37.28%

-15.47%

-21.81%

Max Drawdown (3Y)

Largest decline over 3 years

-40.09%

-24.42%

-15.67%

Max Drawdown (5Y)

Largest decline over 5 years

-53.99%

-38.77%

-15.22%

Max Drawdown (10Y)

Largest decline over 10 years

-53.99%

-43.63%

-10.36%

Current Drawdown

Current decline from peak

-33.01%

0.00%

-33.01%

Average Drawdown

Average peak-to-trough decline

-16.05%

-17.57%

+1.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.63%

6.53%

+13.10%

Volatility

RMD vs. JPM - Volatility Comparison

ResMed Inc. (RMD) has a higher volatility of 12.04% compared to JPMorgan Chase & Co. (JPM) at 5.83%. This indicates that RMD's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RMDJPMDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.04%

5.83%

+6.21%

Volatility (6M)

Calculated over the trailing 6-month period

22.35%

16.44%

+5.91%

Volatility (1Y)

Calculated over the trailing 1-year period

26.82%

22.16%

+4.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.42%

24.40%

+7.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.67%

27.30%

+4.37%

Dividends

RMD vs. JPM - Dividend Comparison

RMD's dividend yield for the trailing twelve months is around 1.23%, less than JPM's 1.70% yield.


PositionTTM20252024202320222021202020192018201720162015
JPM
JPMorgan Chase & Co.
1.70%1.72%1.92%2.38%2.98%2.34%2.83%2.37%2.54%1.91%2.13%2.54%
RMD
ResMed Inc.
1.23%0.94%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%

Financials

RMD vs. JPM - Financials Comparison

This section allows you to compare key financial metrics between ResMed Inc. and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
1.43B
82.46B
(RMD) Total Revenue
(JPM) Total Revenue
Values in USD except per share items

RMD vs. JPM - Profitability Comparison

The chart below illustrates the profitability comparison between ResMed Inc. and JPMorgan Chase & Co. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
62.3%
66.5%
Portfolio components
RMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.

JPM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, JPMorgan Chase & Co. reported a gross profit of 54.83B and revenue of 82.46B. Therefore, the gross margin over that period was 66.5%.

RMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.

JPM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, JPMorgan Chase & Co. reported an operating income of 27.52B and revenue of 82.46B, resulting in an operating margin of 33.4%.

RMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.

JPM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, JPMorgan Chase & Co. reported a net income of 21.16B and revenue of 82.46B, resulting in a net margin of 25.7%.


Frequently Asked Questions


RMD and JPM have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RMD has higher volatility (12.04%) compared to JPM (5.83%). In terms of maximum drawdown, RMD dropped -61.61% vs JPM's -76.16%.

JPM currently has the higher Sharpe Ratio (0.97 vs -1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RMD and JPM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer